Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP3A4 | P08684 | 5/20 | 0.43 |
| ▸ | TSHR | P16473 | 4/20 | 0.43 |
| ▸ | TDP1 | Q9NUW8 | 3/20 | 0.43 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.43 |
| ▸ | MAPT | P10636 | 2/20 | 0.43 |
| ▸ | TP53 | P04637 | 1/20 | 0.43 |
| ▸ | GAA | P10253 | 1/20 | 0.43 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.38 |
| ▸ | POLB | P06746 | 1/20 | 0.37 |
| ▸ | CYP2D6 | P10635 | 2/20 | 0.36 |
| ▸ | SLC6A4 | P31645 | 2/20 | 0.36 |
| ▸ | KCNH2 | Q12809 | 2/20 | 0.36 |
| ▸ | ABCB11 | O95342 | 1/20 | 0.36 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.36 |
| ▸ | AR | P10275 | 1/20 | 0.36 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.36 |
| ▸ | PDE4A | P27815 | 1/20 | 0.36 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.36 |
| ▸ | SIGMAR1 | Q99720 | 1/20 | 0.36 |
| ▸ | HTT | P42858 | 3/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Bromide SCHEMBL28652019 | 0.97 | CYP3A4 (0.42) | CYP3A4TSHRTDP1ALDH1A1MAPT | |
| SCHEMBL146892 | 0.86 | ALDH1A1 (0.58) | CYP3A4TSHRTDP1ALDH1A1MAPT | |
| SCHEMBL29210 | 0.80 | GAA (0.65) | CYP3A4TSHRTDP1ALDH1A1MAPT | |
| SCHEMBL1392743 | 0.79 | ALDH1A1 (0.65) | CYP3A4TSHRTDP1ALDH1A1MAPT | |
| SCHEMBL159075 | 0.79 | ALDH1A1 (0.43) | CYP3A4TSHRTDP1ALDH1A1MAPT | |
| SCHEMBL80048 | 0.79 | KDM4E (0.45) | CYP3A4TSHRTDP1ALDH1A1MAPT | |
| SCHEMBL8132358 | 0.79 | MAPT (0.65) | CYP3A4TSHRTDP1ALDH1A1MAPT | |
| Bromide SCHEMBL10915130 | 0.77 | KDM4E (0.43) | CYP3A4TSHRTDP1ALDH1A1MAPT | |
| SCHEMBL2427550 | 0.75 | CYP3A4 (0.40) | CYP3A4TSHRTDP1ALDH1A1MAPT | |
| SCHEMBL5346206 | 0.75 | CYP3A4 (0.40) | CYP3A4TSHRTDP1ALDH1A1TP53 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 36 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118619842-A | Preparation method of 2-amino-5-bromo-N, 3-dimethylbenzamide | 浙江予睿化学科技有限公司 | 2024-09-10 | — | — | CN | claimed |
| EP-0150787-A2 | Compound having antibronchopneumopathic activity, process for its preparation and pharmaceutical compositions containing it | PULITZER ITALIANA S.p.A. (IT) | 1985-08-07 | — | — | EP | claimed |
| EP-3927685-B1 | A PROCESS FOR THE SYNTHESIS ANTHRANILIC DIAMIDE COMPOUNDS AND INTERMEDIATES THEREOF | PI INDUSTRIES LTD (IN) | 2025-10-08 | — | — | EP | disclosed |
| CN-111065626-B | Compounds for the treatment of huntington's disease | PTC医疗公司 | 2024-09-27 | — | — | CN | disclosed |
| CN-118619842-A | Preparation method of 2-amino-5-bromo-N, 3-dimethylbenzamide | 浙江予睿化学科技有限公司 | 2024-09-10 | — | — | CN | disclosed |
| CN-118619842-A | Preparation method of 2-amino-5-bromo-N, 3-dimethylbenzamide | 浙江予睿化学科技有限公司 | 2024-09-10 | — | — | CN | disclosed |
| US-11718584-B2 | Process for the synthesis anthranilic diamide compounds and intermediates thereof | PI INDUSTRIES LTD. (IN) | 2023-08-08 | — | — | US | disclosed |
| US-11718584-B2 | Process for the synthesis anthranilic diamide compounds and intermediates thereof | PI INDUSTRIES LTD. (IN) | 2023-08-08 | — | — | US | disclosed |
| US-11718584-B2 | Process for the synthesis anthranilic diamide compounds and intermediates thereof | PI INDUSTRIES LTD. (IN) | 2023-08-08 | — | — | US | disclosed |
| US-20230159536-A1 | PYRROLOPYRIMIDINE AMINES AS COMPLEMENT INHIBITORS | WILMINGTON TRUST, NATIONAL ASSOCIATION | 2023-05-25 | — | — | US | disclosed |
| US-20230159536-A1 | PYRROLOPYRIMIDINE AMINES AS COMPLEMENT INHIBITORS | WILMINGTON TRUST, NATIONAL ASSOCIATION | 2023-05-25 | — | — | US | disclosed |
| WO-2012007352-A1 | AQUEOUS COMPOSITION COMPRISING BROMHEXINE | BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) | 2012-01-19 | — | — | WO | disclosed |
| EP-1988144-A1 | ORGANIC ELECTROLUMINESCENCE ELEMENT MATERIAL, ORGANIC ELECTROLUMINESCENCE ELEMENT, DISPLAY DEVICE AND ILLUMINATING DEVICE | KONICA MINOLTA HOLDINGS, INC. (JP) | 2008-11-05 | — | — | EP | disclosed |
| US-20080242685-A1 | Chemical Compounds | SMITHKLINE BEECHAM CORPORATION | 2008-10-02 | — | — | US | disclosed |
| WO-2007023072-A2 | USE OF AMBROXOL FOR THE TREATMENT OF RHINOVIRUS INFECTIONS | BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) | 2007-03-01 | — | — | WO | disclosed |
| US-4925984-A | REACTION WITH BROMINE IN SOLUTION | ETHYL CORPORATION (US) | 1990-05-15 | — | — | US | disclosed |
| EP-0150787-A2 | Compound having antibronchopneumopathic activity, process for its preparation and pharmaceutical compositions containing it | PULITZER ITALIANA S.p.A. (IT) | 1985-08-07 | — | — | EP | disclosed |
| US-4233055-A | Quaternary ammonioalkanecarboxylic acid anilides as plant growth influencing agents | CIBA-GEIGY CORPORATION (US) | 1980-11-11 | — | — | US | disclosed |
| US-4141718-A | ANTIGROWTH AGENTS FOR PLANTS | CIBA-GEIGY CORPORATION (US) | 1979-02-27 | — | — | US | disclosed |
| US-3978040-A | Process for the preparation of cyanoazo compounds by reacting halogenoazo compounds with CuCN in an aqueous media in the presence of a nitrogen base | BAYER AKTIENGESELLSCHAFT (DT) | 1976-08-31 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11718584-B2 | Process for the synthesis anthranilic diamide compounds and intermediates thereof | DAO, DDC, QDPR | CYP3A4 44/4885TSHR 1587/4885TDP1 4302/4885 |
| US-20080242685-A1 | Chemical Compounds | NFKBIA, IKBKG, NFKB2 | CYP3A4 1275/4885TSHR 2303/4885TDP1 1044/4885 |
| US-20230159536-A1 | PYRROLOPYRIMIDINE AMINES AS COMPLEMENT INHIBITORS | C5, C9, C1QBP | CYP3A4 1364/4885TSHR 3407/4885TDP1 255/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.